EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The influence of age-independent somatic driver alterations on clinical outcomes in paediatric and young adult thyroid cancer

Sule Canberk iD, Amber Isaza iD, Mya Bojarsky iD, Mariana Simplício, Helena Barroca, Serra Z Akkoyunlu, Güven Günver, Isabel Almeida, Filippo Dello Iacovo, Anna M Carillo, Mariantonia Nacchio, Elena Vigliar und 9 weitere

European Thyroid Journal · 01.02.2026 · 15 (1)

DOI: 10.1530/etj-25-0310 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Thyroid Journal, online erschienen am 07.01.2026. Verfasst von Sule Canberk und 20 weiteren Autor:innen. Beteiligte Einrichtung: RISE-Health, Department of Pathology, Faculty of Medicine of The University of Porto,Porto, Portugal. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Paediatric and young adult differentiated thyroid carcinoma (DTC) often presents at an advanced stage but carries an excellent prognosis. While age-related genomic differences from adult DTC are recognized, it remains unclear whether outcomes are driven by age or tumour biology.

Methods

We analysed a multi-institutional cohort of 363 patients aged 0–25 years who underwent molecular testing and surgical management. Age was categorized using cut-offs at ≤8, 9–14, 15–18, and 19–25 years. The primary endpoint was disease status at last follow-up, categorized according to American Thyroid Association (ATA) response criteria. Multivariable ordered logistic regression was used to test the independent prognostic effect of somatic driver mutations while adjusting for age, sex, and follow-up duration.

Results

Distinct age-related patterns of oncogenic drivers were observed: RET and NTRK1/3 fusions were predominant in younger patients, BRAF V600E was most frequent in adolescents, and RAS mutations were enriched in young adults. After adjustment, driver mutations independently predicted long-term outcomes. NTRK1/3 fusions (aOR = 5.29, 95% CI: 1.77–15.79), BRAF V600E (aOR = 3.45, 95% CI: 1.37–8.70), and RET fusions (aOR = 3.34, 95% CI: 1.13–9.90) were associated with significantly higher odds of a non-excellent outcome. Conversely, RAS mutations showed a favourable trend, and all DICER1-mutant cases achieved excellent outcomes. While prognosis steadily improved with age, mutation status remained the dominant factor determining outcomes.

Conclusion

Somatic drivers offer prognostic insights independent of age in paediatric and young adult DTC, establishing a molecular framework for precision risk stratification that complements traditional clinical staging and age-based assessments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsHumansAdolescentChildMaleFemaleYoung AdultChild, PreschoolInfantAge FactorsAdultMutationPrognosisProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-retReceptor, trkAInfant, NewbornReceptor, trkC

Stichwörter der Autor:innen

BRAF V600EPaediatric age strataRET and NTRK fusionspaediatric age groupspaediatric thyroid carcinomaprecision oncologysomatic driver alterations

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanProto-Oncogene Proteins c-retReceptor, trkARET protein, humanReceptor, trkC

Autor:innen und Institutionen

  • RISE-Health, Department of Pathology, Faculty of Medicine of The University of Porto,Porto, Portugal.
  • Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Serviço de Anatomia Patológica, Centro Hospitalar Universitário de S João, Porto, Portugal.
  • Department of Biostatistics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Department of Public Health, University of Naples Federico II, Naples, Italy.
  • Pediatric Otolaryngology - Head and Neck Surgery at Vanderbilt Children's Hospital,Nashville, Tennessee, USA.

ORCID-Profile: Sule Canberk, Amber Isaza, Mya Bojarsky, Andrew Bauer

Zitieren

APA

Canberk, S., Isaza, A., Bojarsky, M., Simplício, M., Barroca, H., Akkoyunlu, S. Z., Günver, G., Almeida, I., Dello Iacovo, F., Carillo, A. M., Nacchio, M., Vigliar, E., Bellevicine, C., Troncone, G., Larkin, R., Belcher, R. H., Weiss, V., Wang, H., Baloch, Z., …, & Bauer, A. (2026). The influence of age-independent somatic driver alterations on clinical outcomes in paediatric and young adult thyroid cancer. European Thyroid Journal, 15(1). https://doi.org/10.1530/etj-25-0310

Vancouver

Canberk S, Isaza A, Bojarsky M, Simplício M, Barroca H, Akkoyunlu SZ, et al. The influence of age-independent somatic driver alterations on clinical outcomes in paediatric and young adult thyroid cancer. European Thyroid Journal. 2026;15(1). doi:10.1530/etj-25-0310

BibTeX
@article{Canberk2026,
  author = {Canberk, Sule and Isaza, Amber and Bojarsky, Mya and Simplício, Mariana and Barroca, Helena and Akkoyunlu, Serra Z and Günver, Güven and Almeida, Isabel and Dello Iacovo, Filippo and Carillo, Anna M and Nacchio, Mariantonia and Vigliar, Elena and Bellevicine, Claudio and Troncone, Giancarlo and Larkin, Riley and Belcher, Ryan H and Weiss, Vivian and Wang, Huiying and Baloch, Zubair and Schmitt, Fernando and Bauer, Andrew},
  title = {The influence of age-independent somatic driver alterations on clinical outcomes in paediatric and young adult thyroid cancer},
  journal = {European Thyroid Journal},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1530/etj-25-0310}
}
Kostenlos starten →